BioSpace News Archive

Press Releases

OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

May 16, 2025
·
8 min read
Press Releases

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 16, 2025

May 16, 2025
·
2 min read
Press Releases

Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

May 16, 2025
·
9 min read
Press Releases

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

May 16, 2025
·
7 min read
Press Releases

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV

May 16, 2025
·
5 min read
Press Releases

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma

May 16, 2025
·
18 min read
Press Releases

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

May 16, 2025
·
3 min read
Press Releases

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

May 16, 2025
·
3 min read
Press Releases

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

May 16, 2025
·
4 min read
Press Releases

Neurocrine Biosciences to Present Wide-Ranging One-Year Data from Phase 3 CAHtalyst™ Pediatric Study at Pediatric Endocrine Society 2025 Annual Meeting

May 16, 2025
·
13 min read